Pune, India, Feb. 15, 2023 (GLOBE NEWSWIRE) -- The latex agglutination test kits market size was valued at USD 447.2 million in 2021 and USD 462.4 million in 2022. The market is expected to reach USD 620.0 million by 2029 with a CAGR of 4.3% during the forecast period. Latex agglutination test kits are used to detect antigens from Cerebrospinal Fluid (CSF), blood, urine, and saliva. The presence of such tests provides an effective measure to combat diseases, which is expected to propel the market course. Fortune Business Insights™ shares this information in its report titled “Latex Agglutination Test Kits Market, 2022-2029.
Industry Development:
April 2022- Bio-Rad Laboratories, Inc. showcased its complete range of infectious disease testing systems, reagents, and quality controls for optimizing testing workflows by participating in the 32nd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) 2022.
Request a Free Sample Copy of the Research Report:
Report Scope & Segmentation
| Report Coverage | Details |
| Forecast Period | 2022 to 2029 |
| Forecast Period 2022 to 2029 CAGR | 4.3% |
| 2029 Value Projection | USD 620.0 million |
| Base Year | 2021 |
| Market Size in 2021 | USD 447.2 million |
| Historical Data | 2018 to 2020 |
| No. of Pages | 130 |
Key Takeaways from the Latex Agglutination Test Kits Market:
- Hepatitis, meningitis, rheumatoid arthritis, tonsillitis, and other streptococcal diseases are frequently diagnosed with latex agglutination test kits
- The market is divided into two categories based on test type: antigen testing and antibody detection
- North America is expected to dominate the global market, with a market size of USD 203.5 million in 2021
- The market's largest segment is the antigen testing category
- An increase in hospital-based laboratories and an increase in the incidence of infectious and autoimmune diseases all contribute to the growth of the global market
DRIVING FACTOR:
Variegated Application of Test Kits to Progress Market Development
Variegated application of these kits is anticipated to drive the latex agglutination test kits market growth. They are used for hepatitis, meningitis, rheumatoid arthritis, tonsillitis, and other streptococcal infections. Diagnosis of various infectious and autoimmune diseases to lead to positive market trajectory. Various clinical studies showcase a scientific basis regarding the efficacy of these test kits, eventually promoting patient adoption in the market. Autoimmune diseases, such as lupus and rheumatoid arthritis, are also prominent contributing factors for market growth.
However, the emergence of new and reliable alternative diagnostics is expected to hamper the market growth.
Browse Complete Report Details: https://www.fortunebusinessinsights.com/latex-agglutination-test-kits-market-107155
REGIONAL INSIGHTS:
North America to Lead the Market Owing to Increasing Usage of Such Kits
North America is expected to have the largest latex agglutination test kits market share due to increasing usage of such kits and number of Clinical Laboratory Improvement Amendments (CLIA) certified laboratories.
Europe was the second-largest market in 2021 due to surging R&D activities to detect the efficacy of these kits and government expenditure to offer diagnostic care for patients.
Asia Pacific had the highest CAGR as the region had significant proportion of the global burden of infectious diseases. Rising incidence of infectious diseases will boost the promotion of latex agglutination testing.
Segments
Antigen Testing to Lead Due to Large Number of Patients Being Affected By Various Diseases
On the basis of test type, the market is divided into antibody detection and antigen testing. The antigen testing segment is further sub-segmented into streptococcus, staphylococcus aureus, escherichia coli, and others.
The antigen testing segment accounted for the dominant part owing to a large number of patient population affected by various bacterial, viral, and fungal diseases. Antibody detection segment is also set to witness a significant growth due to increasing adoption of antibody testing by latex agglutination test kits and the rising prevalence of diseases.
Blood Segment to Dictate as it is Used in Antigen and Antibody Test Kits
Based on sample type, the market is categorized into blood, urine, cerebrospinal fluid (lumbar puncture), and others. The blood segment is anticipated to dominate the market as it is widely used in antigen and antibody latex agglutination test kits. Urine segment also had substantial impact as urine samples are commonly taken to detect human chorionic gonadotropin (hCG) hormones and fibrin.
Hospital-based Laboratories to Govern Owing to Favorable Health Reimbursement Policies
According to end-user, the market is bifurcated into hospital-based laboratories and standalone clinical laboratories. Hospital-based laboratories segment is projected to govern due to favorable health reimbursement policies for infectious diseases diagnostics and rising awareness regarding the early diagnosis of infectious diseases.
Quick Buy – https://www.fortunebusinessinsights.com/checkout-page/107155
Competitive Landscape
Partnership Strategies by Key Players to Progress Market Growth
The market has Thermo Fisher Scientific Inc. and Hardy Diagnostics as the key players and they accounted for the major proportion in the market, owing to a large customer base and robust presence of healthcare professionals in their network. Some other key players include Atlas Medical GmbH, HiMedia Laboratories, Liofilchem S.r.l, Bio-Rad Laboratories, Inc., Pro Lab Diagnostics Inc., Arlington Scientific, Inc., Biotec (Novacyt), and others. In June 2021, Bio-Rad Laboratories, Inc. signed a partnership with Seegene for the clinical development and commercialization of infectious disease molecular diagnostic products.
The Report Lists the Key Companies in the Latex Agglutination Test Kits Market:
- Atlas Medical GmbH (Germany)
- Thermo Fisher Scientific Inc. (U.S.)
- Bio-Rad Laboratories, Inc. (U.S.)
- HiMedia Laboratories (India)
- Pro Lab Diagnostics Inc. (Canada)
- Arlington Scientific, Inc. (U.S.)
- Hardy Diagnostics (U.S.)
- Liofilchem S.r.l. (Italy)
- Biotec (Novacyt) (U.K.)
Some major points from Table of Content:
- Key Insights
- Prevalence of Key Infectious Diseases, By Key Countries, 2021
- Key Industry Developments
- Economic Burden of Infectious Diseases, By Key Countries, 2021
- Impact of COVID-19 on the Market
- Global Latex Agglutination Test Kits Market Analysis, Insights and Forecast, 2018-2029
- Market Analysis, Insights and Forecast – By Test Type
- Antibody Detection
- Antigen Testing
- Market Analysis, Insights and Forecast – By Test Type
-
-
-
- Streptococcus
- Staphylococcus Aureus
- Escherichia Coli
- Others
-
-
- North America Latex Agglutination Test Kits Market Analysis, Insights and Forecast, 2018-2029
- Market Analysis, Insights and Forecast – By Test Type
- Antibody Detection
- Antigen Testing
- Market Analysis, Insights and Forecast – By Test Type
-
- Market Analysis, Insights and Forecast – By Sample Type
- Blood
- Urine
- Cerebrospinal Fluid (Lumber Puncture)
- Others
- Market Analysis, Insights and Forecast – By End User
- Hospital-based Laboratories
- Standalone Clinical Laboratories
- Market Analysis, Insights and Forecast – By Region
- North America
- Europe
- Asia Pacific
- Rest of the World
- Market Analysis, Insights and Forecast – By Sample Type
-
-
-
- Streptococcus
- Staphylococcus Aureus
- Escherichia Coli
- Others
-
-
- Europe Latex Agglutination Test Kits Market Analysis, Insights and Forecast, 2018-2029
- Market Analysis, Insights and Forecast – By Test Type
- Antibody Detection
- Antigen Testing
- Market Analysis, Insights and Forecast – By Test Type
-
- Market Analysis, Insights and Forecast – By Sample Type
- Blood
- Urine
- Cerebrospinal Fluid (Lumber Puncture)
- Others
- Market Analysis, Insights and Forecast – By End User
- Hospital-based Laboratories
- Standalone Clinical Laboratories
- Market Analysis, Insights and Forecast – By Country
- U.S.
- Canada
- Market Analysis, Insights and Forecast – By Sample Type
-
-
-
- Streptococcus
- Staphylococcus Aureus
- Escherichia Coli
- Others
-
-
- Asia Pacific Latex Agglutination Test Kits Market Analysis, Insights and Forecast, 2018-2029
- Market Analysis, Insights and Forecast – By Test Type
- Antibody Detection
- Antigen Testing
- Market Analysis, Insights and Forecast – By Test Type
-
- Market Analysis, Insights and Forecast – By Sample Type
- Blood
- Urine
- Cerebrospinal Fluid (Lumber Puncture)
- Others
- Market Analysis, Insights and Forecast – By End User
- Hospital-based Laboratories
- Standalone Clinical Laboratories
- Market Analysis, Insights and Forecast – By Country/ Sub-Region
- Germany
- U.K.
- France
- Spain
- Italy
- Scandinavia
- Rest of Europe
- Market Analysis, Insights and Forecast – By Sample Type
-
-
-
- Streptococcus
- Staphylococcus Aureus
- Escherichia Coli
- Others
-
-
- Rest of the World Latex Agglutination Test Kits Market Analysis, Insights and Forecast, 2018-2029
- Market Analysis, Insights and Forecast – By Test Type
- Antibody Detection
- Market Analysis, Insights and Forecast – By Test Type
-
- Market Analysis, Insights and Forecast – By Sample Type
- Blood
- Urine
- Cerebrospinal Fluid (Lumber Puncture)
- Others
- Market Analysis, Insights and Forecast – By End User
- Hospital-based Laboratories
- Standalone Clinical Laboratories
- Market Analysis, Insights and Forecast – By Country/ Sub-Region
- Market Analysis, Insights and Forecast – By Sample Type
TOC Continued…
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/latex-agglutination-test-kits-market-107155
Related Links:
Meningitis Diagnostic Testing Market Size, Share, Growth Industry Report, 2023-2030
Point-Of-Care Coagulation Testing Devices Market Share, Size, Demand and Forecast 2023-2028
Legionella Testing Market Size, Share, Growth Industry Report, 2020-2027
Infectious Disease Molecular Diagnostics Market Share, Size, Demand and Forecast 2023-2030
Molecular Diagnostics Market Size, Share, Growth Industry Report, 2018-2025
About Us:
Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
Pune - 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
